Southern California College of Optometry   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Fullerton CA United States (1904)

Organization Overview

First Clinical Trial
2005
NCT00315302
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

bepotastine (bepreve) (1 trial)

loteprednol (lotemax) (1 trial)

polyethylene glycol (1 trial)

Drugs in Phase 3 Trials (1)

atropine (1 trial)

Drugs in Other Trials (2)

carboxymethyl cellulose (2 trials)

glycerin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amblyopia (Phase 3)

Conjunctivitis (Phase 4)

Conjunctivitis, Allergic (Phase 4)

Dry Eye Syndromes (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 6